Radiopharm Theranostics Limited (RADX) Operating cash flow 2023–2025
Radiopharm Theranostics Limited (RADX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$36.6MFY2025 · since FY2023: -$23.2M → -$36.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.6M | -59.5% |
| FY2024 | -$23.0M | +1.0% |
| FY2023 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RADX financial trends
RADX RevenueRADX Net incomeRADX Net marginRADX Gross profitRADX Gross marginRADX Operating incomeRADX Operating marginRADX Free cash flowRADX Capital expendituresRADX Return on equityRADX Stock buybacksRADX Dividends paidRADX Total assetsRADX Total liabilitiesRADX Shareholders’ equityRADX overview →